81 results
8-K
GYRE
Gyre Therapeutics Inc
14 Feb 24
Results of Operations and Financial Condition
5:16pm
, 2023, Catalyst held a special meeting of stockholders at which the Transactions were approved.
On October 30, 2023, the Transactions contemplated
8-K
EX-10.1
GYRE
Gyre Therapeutics Inc
2 Nov 23
Changes in Registrant's Certifying Accountant
5:00pm
be an employee of the Company, provided that, subject to your election by the stockholders of the Company as a Class II director at the special meeting
424B3
GYRE
Gyre Therapeutics Inc
1 Nov 23
Prospectus supplement
5:18pm
will be completed prior to the Outside Date (as defined in the Business Combination Agreement).
Further, at the Special Meeting, stockholders … at the special meeting of stockholders of the Company held on August 29, 2023 (the “Special Meeting”).
Completion of the Transactions is subject to receipt
S-8
EX-4.7
GYRE
Gyre Therapeutics Inc
30 Oct 23
Registration of securities for employees
5:46pm
2.2 Special Meeting. Except as otherwise required by law, and except as otherwise provided for or fixed pursuant to the Certificate of Incorporation … ”), a special meeting of the stockholders of the Corporation may be called at any time only by the Chair of the Board of Directors, the Chief Executive
8-K
EX-99.1
hz9cl97qyut4x
30 Oct 23
Entry into a Material Definitive Agreement
5:17pm
8-K
blz393gclw2b
30 Oct 23
Entry into a Material Definitive Agreement
5:17pm
8-K
EX-3.3
ychgnnyrbjzga vnrvjf
30 Oct 23
Entry into a Material Definitive Agreement
5:17pm
424B3
z5zq7
27 Oct 23
Prospectus supplement
5:10pm
CORRESP
4dcwljz3ky8yf9 cnk9
13 Oct 23
Correspondence with SEC
12:00am
8-K
f12t4pm0tvnw
31 Aug 23
Entry into a Material Definitive Agreement
4:17pm
UPLOAD
9o578l
3 Aug 23
Letter from SEC
12:00am
DEFM14A
6edn455x
20 Jul 23
Proxy related to merger
8:57am
DEFA14A
motm0hb zc9sp2y
20 Jun 23
Additional proxy soliciting materials
5:02pm
8-K
2uomhpzm2le6
20 Jun 23
Material Modifications to Rights of Security Holders
5:00pm